Product How it works Pricing Blog FAQ About Contact
Gyre Therapeutics

Gyre Therapeutics (NASDAQ: GYRE) revenue

Gyre Therapeutics reported revenue of $116.6m for fiscal 2025, 10.2% more than in fiscal 2024 ($105.8m). Since fiscal 2017 its revenue has grown by 11,352.7%, an average growth of 80.9% a year.

Fiscal 2025 is the highest of the 8 fiscal years on record for Gyre Therapeutics. The biggest drop was in fiscal 2018, −99.4%.

Revenue, in millions of US dollars1.020170.0201820.920207.32021102.32022113.52023105.82024116.62025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$116.6m+10.2%$11.5m9.9%
2024$105.8m−6.8%$16.2m15.3%
2023$113.5m+10.9%−$67.2m−59.3%
2022$102.3m+1,294.0%$9.2m9.0%
2021$7.3m−65.0%−$87.9m−1,197.8%
2020$20.9m—−$57.4m−273.9%
2018$0.0m−99.4%−$33.8m−563,700.0%
2017$1.0m—−$21.8m−2,143.6%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Gyre Therapeutics revenue compared with its sector

By revenue for its latest fiscal year, Gyre Therapeutics ranks 275th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Gyre Therapeutics, 10.2%.

RankCompanyRevenueRevenue growth
273rdXencor$125.6m13.7%
274thMonte Rosa Therapeutics$123.7m63.5%
275thGyre Therapeutics$116.6m10.2%
276thOraSure Technologies$115.0m−38.1%
277thAgenus$114.2m10.4%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Gyre Therapeutics

How much revenue did Gyre Therapeutics make in fiscal 2025?
Gyre Therapeutics reported revenue of $116.6m for fiscal 2025, compared with $105.8m in fiscal 2024.
How much has the revenue of Gyre Therapeutics grown?
Between fiscal 2017 and fiscal 2025 it went from $1.0m to $116.6m: 11,352.7% more, an average growth of 80.9% a year.
What was the best year for revenue at Gyre Therapeutics?
Of its last 8 fiscal years, fiscal 2025, with $116.6m.
Where does Gyre Therapeutics rank in its sector by revenue?
It ranks 275th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Gyre Therapeutics come from?
From the annual report (Form 10-K) that Gyre Therapeutics files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Gyre Therapeutics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2018 · 2017. More on Gyre Therapeutics: the Gyre Therapeutics page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.